跳至主要内容
临床试验/JPRN-UMIN000049064
JPRN-UMIN000049064已完成Unknown

Effects of consumption of the test food on urination-related quality of life: a randomized, placebo-controlled, double-blind, parallel-group comparison study - Effects of consumption of the test food on urination-related quality of life

ORTHOMEDICO Inc.0 个研究点目标入组 56 人开始时间: 2023年9月28日最近更新:

试验速览

阶段
Unknown
状态
已完成
入组人数
56

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 64years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, and myocardial infarction 2. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 3. Subjects who are currently undergoing treatment for any of the following chronic diseases: urination disorder, sleep disorder, cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 4. Subjects who use or take "Foods for Specified Health Uses", "Foods with Functional Claims", or particularly urination-related health food on a daily basis 5. Subjects who drink to excess (average of more than about 20 g/day as absolute alcohol intake) {500 mL: a medium bottle of beer or about 1.5 cans of canned chu-hi, 180 mL: 1 go of sake or about 1.5 glasses of wine, 90 mL: half-go with shochu, 60 mL: a glass of whiskey brandy (double)} 6. Subjects whose sleeping time or habit is irregular due to work such as a late-night shift 7. Subjects whose sleeping and waking time are irregular and whose sleeping hours is five or less 8. Subjects who sleep with more than one person 9. Subjects who take health food or nutritional supplement with anti-oxidative capacity 10. Subjects who are currently taking medications (including herbal medicines) and supplements 11. Subjects who are allergic to medicines and/or the test food related products 12. Subjects who are pregnant, lactating, or planning to become pregnant during this trial 13. Subjects who suffer from COVID-19 14. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 15. Subjects who are judged as ineligible to participate in this study by the physician

研究者

相似试验